متعب النامي
讚了
$Clearmind Medicine (CMND.US)$ 2.80美元的壓力位為下一輪運行提供支持，做得好，每位持有者👍🏻
已翻譯
1
متعب النامي
讚了
⭐️
關注每晚關注列表
$Baudax Bio (BXRX.US)$ $Cal-Maine Foods (CALM.US)$ $Cosmos Health (COSM.US)$ $Dermata Therapeutics (DRMA.US)$ $Evaxion Biotech (EVAX.US)$ $First Wave BioPharma (FWBI.US)$ $Hoth Therapeutics (HOTH.US)$ $KALA BIO (KALA.US)$ $LightJump Acquisition Corp (LJAQ.US)$ $Palisade Bio (PALI.US)$ $美高梅 (MGM.US)$ $PDS Biotechnology (PDSB.US)$ $SatixFy Communications (SATX.US)$ $TG Therapeutics (TGTX.US)$ $Tuesday Morning Corp (TUEM.US)$
關注每晚關注列表
$Baudax Bio (BXRX.US)$ $Cal-Maine Foods (CALM.US)$ $Cosmos Health (COSM.US)$ $Dermata Therapeutics (DRMA.US)$ $Evaxion Biotech (EVAX.US)$ $First Wave BioPharma (FWBI.US)$ $Hoth Therapeutics (HOTH.US)$ $KALA BIO (KALA.US)$ $LightJump Acquisition Corp (LJAQ.US)$ $Palisade Bio (PALI.US)$ $美高梅 (MGM.US)$ $PDS Biotechnology (PDSB.US)$ $SatixFy Communications (SATX.US)$ $TG Therapeutics (TGTX.US)$ $Tuesday Morning Corp (TUEM.US)$
已翻譯
13
1
متعب النامي
表達了心情
如何看到露西 FSTX 不會發生神經的情況
$KALA BIO (KALA.US)$ $WiSA Technologies (WISA.US)$ $Innovative Eyewear (LUCY.US)$ $F-star Therapeutics (FSTX.US)$ $Jounce Therapeutics (JNCE.US)$ $Minerva Surgical (UTRS.US)$ $Oric Pharmaceuticals (ORIC.US)$ $Minerva Neurosciences (NERV.US)$ $Argo Blockchain (ARBK.US)$ $Acasti Pharma (ACST.US)$
$KALA BIO (KALA.US)$ $WiSA Technologies (WISA.US)$ $Innovative Eyewear (LUCY.US)$ $F-star Therapeutics (FSTX.US)$ $Jounce Therapeutics (JNCE.US)$ $Minerva Surgical (UTRS.US)$ $Oric Pharmaceuticals (ORIC.US)$ $Minerva Neurosciences (NERV.US)$ $Argo Blockchain (ARBK.US)$ $Acasti Pharma (ACST.US)$
已翻譯
3
متعب النامي
讚了
![[empty]](https://static.moomoo.com/node_futunn_nnq/assets/images/folder.5c37692712.png)
![[error]](https://static.moomoo.com/node_futunn_nnq/assets/images/no-network.991ae8055c.png)
![[loading]](data:image/svg+xml;base64,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)